CAS: 937272-79-2 - Pacritinib
Formula:C28H32N4O3
InChI:InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+
InChI key:InChIKey=HWXVIOGONBBTBY-ONEGZZNKSA-N
SMILES:N1=CC=C2NC1=NC3=CC=C(OCCN4CCCC4)C(=C3)COCC=CCOCC5=CC=CC2=C5
- Synonyms:
- 14,19-Dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 11-[2-(1-pyrrolidinyl)ethoxy]-, (16E)-
- (16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene
- SB 1518
- Pacritinib
(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene
CAS:937272-79-2
Formula:
C28H32N4O3
Purity:
97%
Color and Shape:
Solid
Molecular weight:
472.5787
Ref: IN-DA003A49
1g | To inquire | ||
1mg | 53.00 € | ||
2mg | 64.00 € | ||
5mg | 120.00 € | ||
10mg | 166.00 € | ||
100mg | 269.00 € | ||
250mg | 480.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Pacritinib
CAS:937272-79-2
Pacritinib (SB1518) (SB1518) is an effective and specific inhibitor of JAK2 and FLT3 (IC50: 23/22 …
Formula:
C28H32N4O3
Purity:
99.27% - ≥95%
Color and Shape:
Solid
Molecular weight:
472.58
Ref: TM-T6020
2mg | 40.00 € | ||
5mg | 59.00 € | ||
10mg | 96.00 € | ||
25mg | 148.00 € | ||
50mg | 222.00 € | ||
100mg | 368.00 € | ||
500mg | 866.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Pacritinib
Controlled ProductCAS:937272-79-2
Formula:
C28H32N4O3
Color and Shape:
Neat
Molecular weight:
472.579
Ref: TR-P133700
200mg | 15,234.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Pacritinib
CAS:937272-79-2
Pacritinib is a selective inhibitor of the tyrosine kinase JAK2. It has been shown to …
Formula:
C28H32N4O3
Purity:
Min. 95%
Molecular weight:
472.59 g/mol
Ref: 3D-MMB27279
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025